Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.11.2011 | Case report

Leflunomide/methotrexate/rituximab

Progressive multifocal leukoencephalopathy: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL.Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Archives of Neurology 68: 1156-1164, No. 9, Sep 2011. Available from: URL: http://dx.doi.org/10.1001/archneurol.2011.103 - USA Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL.Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Archives of Neurology 68: 1156-1164, No. 9, Sep 2011. Available from: URL: http://​dx.​doi.​org/​10.​1001/​archneurol.​2011.​103 - USA
Metadaten
Titel
Leflunomide/methotrexate/rituximab
Progressive multifocal leukoencephalopathy: 4 case reports
Publikationsdatum
01.11.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113760-00068

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Ergocalciferol

Case report

Isotretinoin

Case report

Docetaxel

Case report

Docetaxel

Case report

Topiramate